TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
HIMS

Hims Hers Health Inc

Healthcare · Drug Manufacturers - Specialty & Generic

29.70$ +2.3% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Income Statement

Hims Hers Health Inc (HIMS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 753 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement HIMS
Line item Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
18 18 22 25 30 36 41 41 52 61 74 85 101 114 145 167 191 208 227 247 278 316 402 481 586 545 599 618 608 753 2,578
9.4 9.4 9.4 9.6 9.4 10 10 9.6 12 13 19 23 27 26 30 35 37 38 39 43 49 59 84 112 155 129 157 173 308 272 911
8.6 8.6 12 15 21 26 31 32 40 47 55 62 75 87 114 132 153 170 187 204 229 257 318 370 431 416 442 444 300 481 1,668
– – – – – – – – – – 6.2 5.6 6.1 6.9 8.0 8.3 11 12 12 13 15 19 21 24 30 38 41 41 47 55 183
11 11 18 15 14 15 19 6.0 62 34 38 41 22 23 26 50 31 31 36 32 35 41 45 48 49 67 81 76 110 165 432
29 29 32 29 27 27 35 37 89 65 83 84 92 107 134 144 165 179 196 204 219 246 296 351 373 389 430 435 317 578 1,760
-21 -21 -20 -14 -6.2 -1.0 -3.3 -4.6 -48 -17 -28 -22 -17 -20 -20 -12 -11 -9.2 -8.6 -0.4 9.9 11 22 19 58 27 12 9.2 -16 -97 -93
– – – 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 1.6 2.6 1.6 – – 1.6 – – – – – – – – – – –
-20 -20 -19 -12 -6.0 -0.9 -5.8 -5.2 -51 -9.1 -19 -31 -16 -20 -19 -11 -9.7 -7.2 -6.9 2.2 12 13 24 22 60 33 12 18 -102 -93 -164
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 -3.2 -0.1 0.1 0.0 0.0 -0.1 0.4 0.0 0.7 1.0 1.3 0.1 -52 -3.7 11 -9.7 -3.6 -2.2 -9.4 -6.3 -22
-21 -21 -19 -12 -6.0 -1.0 -5.9 -5.2 -51 -9.2 -16 -31 -16 -20 -19 -11 -10 -7.2 -7.6 1.2 11 13 76 26 49 43 16 21 -92 -86 -142
-21 -21 -19 -12 -5.8 -0.7 -5.5 -2.0 -48 -8.6 -18 -30 -14 -18 -17 -9.0 -7.6 -4.8 -4.6 4.9 15 17 28 28 69 43 30 36 -80 -63 -76

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?